We first confirmed that BCL2 is significantly overexpressed at the mRNA and protein levels in HOXA9-positive cells (Figure 7E and 7F), which was consistent with increased levels of BCL2 protein in HOXA9-expressing subcutaneous tumor (Figure 4F). This evidence concerns the gene BCL2 and neoplasm.